Cargando…
Evaluating the Response and Safety of Inactivated COVID-19 Vaccines in Liver Transplant Recipients
PURPOSE: To evaluate the response and safety of an inactivated vaccine (Sinovac Life Sciences Co., Ltd., Beijing, China) for coronavirus disease 2019 (COVID-19) in liver transplant (LTx) recipients from China. PATIENTS AND METHODS: Thirty-five recipients post LTx from the First Affiliated Hospital o...
Autores principales: | Tu, Zhen-Hua, Jin, Ping-Bo, Chen, Di-Yu, Chen, Zhi-Yun, Li, Zhi-Wei, Wu, Jie, Lou, Bin, Zhang, Bao-Shan, Zhang, Lin, Zhang, Wei, Liang, Ting-Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112169/ https://www.ncbi.nlm.nih.gov/pubmed/35592105 http://dx.doi.org/10.2147/IDR.S359919 |
Ejemplares similares
-
Gut microbiota of liver transplantation recipients
por: Sun, Li-Ying, et al.
Publicado: (2017) -
1075 Effectiveness and Safety of Immunization with Live-attenuated and Inactivated Vaccines for Pediatric Liver Transplantation Recipients
por: Ito, Yoshinori, et al.
Publicado: (2014) -
Safety and immunogenicity of COVID-19 vaccination among liver transplant recipients in China
por: Tian, Qiu-Ju, et al.
Publicado: (2022) -
Bile microbiota: new insights into biliary complications in liver transplant recipients
por: Liu, Ying, et al.
Publicado: (2020) -
Do Liver Transplant Recipients Have a Higher Risk for Cryptococcosis Than Non-liver Transplant Recipients?
por: Sun, Hsin-Yun, et al.
Publicado: (2017)